Anders Sjöstedt
Has grant
Professor, Head of Department
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Mechanisms of type VI secretion and its utility as therapeutic target.
Open Date: 2014-01-01
Close Date: 2017-12-01
Grant: Close
Mechanisms effectuating killing of Francisella tularensis with a special focus on reactrive oxygen species and iron and their relationship to vaccine-mediated protection
Open Date: 2013-01-01
Close Date: 2015-12-01
Grant: Close
Development of live Francisella tularensis vaccines
Open Date: 2005-03-01
Close Date: 2011-02-28
Articles (11)
Background Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment outcomes of laboratory-confirmed tularemia cases over an 11-year period in Northern Sweden. Methods Data from reported tularemia cases (aged >10 years at time of study) in Norrbotten county between 2011 and 2021 were collected through review of electronic medical records and participant questionnaires; 415 of 784 accepted participation (52.9%). Of these, 327 were laboratory-confirmed cases (serology and/or polymerase chain reaction). A multivariable logistic regression model was used to investigate variables associated with retreatment. Results Median age of participants was 54 years (interquartile range [IQR], 41.5–65) and 49.2% were female. Although ulceroglandular tularemia was the predominant form (n = 215, 65.7%), there were several cases of pulmonary tularemia (n = 40; 12.2%). Inflammatory markers were largely nonspecific, with monocytosis frequently observed (n = 36/75; 48%). Tularemia was often misdiagnosed on presentation (n = 158, 48.3%), with 65 (19.9%) receiving initial inappropriate antibiotics and 102 (31.2%) retreated. Persistent lymphadenopathy was infrequent (n = 22, 6.7%), with 10 undergoing surgical interventions. In multivariable analysis of variables associated with retreatment, we highlight differences in time until receiving appropriate antibiotics (8 [IQR, 3.25–20.75] vs 7 [IQR, 4–11.25] days; adjusted P = .076), and doxycycline-based treatment regimen (vs ciprofloxacin; adjusted P = .084), although this was not significant after correction for multiple comparisons. Conclusions We comprehensively summarize clinical, laboratory, and treatment outcomes of type B tularemia. Targeting tularemia requires clinical awareness, early diagnosis, and timely commencement of treatment for an appropriate duration.
Year:
2024
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (6)
Aftab Nadeem
Umea University
Marta Bally
Umeå Universitet Medicinska fakulteten
Tomas N Gustafsson
Umea University
Petra Spidlova
University of Defence in Brno
Sun Nyunt Wai
Professor of Medical Microbial Pathogenesis
Umeå Universitet
Pavla Pavlik
University of Defence in Brno
Make your next move.
Prepare your application
Review drafts before you send them.